CoChat
Sign Up
Cited by 137Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsHeart rate and cardiovascular health

The DOI matches its Crossref record; 33 of the 36 references it cites were found in a registry or an index.

Heart Failure Epidemiology: European Perspective

Open access
Guha, K., McDonagh, T.·2013·Current Cardiology Reviews
DOI 10.2174/1573403x11309020005PMC PMC3682396
Open this paper in CoChat — free accountOpen PDF

Abstract

Heart failure poses an increasing problem for global healthcare systems. The epidemiological data which has been accrued over the last thirty years has predominantly been accumulated from experience within North America and Europe. Initial large cohort, prospective longitudinal studies produced the first publications; however latterly the focus has shifted onto epidemiological data governing hospitalisation and mortality. The emphasis behind this shift has been the resource implications with regards to repetitive, costly and prolonged hospitalisation. The European experience in heart failure, though similar to North America has recently demonstrated differences in hospitalisation which may underlie the differences between healthcare system configuration. Heart failure however remains an increasing global problem and the endpoint of a variety of cardiovascular diseases. Allied with the fact of increasingly elderly populations and prior data demonstrating a steep rise in prevalent cases within more elderly populations, it is likely that the increasing burden of disease will continue to pose challenges for modern healthcare. Despite the predicted increase in the number of patients affected by heart failure, over the last thirty years, a clear management algorithm has evolved for the use of pharmacotherapies (neuro-hormonal antagonists), device based therapies (Implantable Cardioverting Defibrillator (ICD) and Cardiac Resynchronisation Therapy (CRT)) and mechanical therapies including left ventricular assist devices and cardiac transplantation. Though the management of such patients has been clearly delineated in national and international guidelines, the underuse of all available and appropriate therapies remains a significant problem. When comparing various epidemiological studies from different settings and timepoints, it should be remembered that rates of prevalence and incidence may vary depending upon the definition used, methods of accumulating information (with the possibility of bias) and the chosen cut point of defining left ventricular systolic dysfunction (LVSD).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1573403x11309020005

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. (1) Demonstrates Treatment Algorithm for Left Ventricular Systolic Dysfunction. ACEI = Ace Inhibitor, BB = Beta Blocker, MRA = Mineralocorticoid Receptor, ARB= Angiotensin II Receptor Antagonist
Fig. (1) Demonstrates Treatment Algorithm for Left Ventricular Systolic Dysfunction. ACEI = Ace Inhibitor, BB = Beta Blocker, MRA = Mineralocorticoid Receptor, ARB= Angiotensin II Receptor AntagonistCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Research works printed but not linked: 2

  1. [30]McDonagh TA Morrison CE Lawrence A Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population Lancet 1997 350 829 33 9310600
  2. [32]Cowie MR Wood DA Coats AJ Incidence and aetiology of heart failure a population-based study Eur Heart J 1999 20 421 8 10213345

Cited by

Sorted by citations

Items 101–136 of 136

Related

See all

Metadata

Authors
Guha, K., & McDonagh, T.
Affiliations
  • Royal Brompton Hospital (GB)
  • King's College Hospital (GB)
Corresponding author
Guha, K.
ORCID
Venue
Current Cardiology Reviews
Publisher
Bentham Science Publishers Ltd.
Published
2013-05-01
Volume
9
Issue
2
Pages
123-127
ISSN
1573-403X (ISSN-L)
DOI
10.2174/1573403x11309020005
PMC
PMC3682396
OpenAlex
W2005877651
Cited by
137
References
36
Citations by year
2025: 9 · 2024: 6 · 2023: 6 · 2022: 9 · 2021: 12 · 2020: 10 · 2019: 15 · 2018: 20 · 2017: 15 · 2016: 17 · 2015: 9 · 2014: 7 · 2013: 2
FWCI
1.99
Type
journal article
Language
en
Open access
Locations
  • Current Cardiology Reviews (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Keywords
heart failure, heart failure epidemiology, prevalence, incidence, hospitalization, mortality, healthcare resource burden, left ventricular systolic dysfunction, implantable cardioverter-defibrillator, cardiac resynchronization therapy, left ventricular assist device, heart transplantation, underuse of therapy, healthcare system differences, older adults
MeSH terms
Echocardiography, Europe, Heart Failure, Heart-Assist Devices, Hospitalization, Humans, Prognosis, Prospective Studies, Comorbidity, Causality, Incidence, Prevalence, Defibrillators, Implantable, Ventricular Dysfunction, Left, Cardiac Resynchronization Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review